Description
A potent HIV-1 protease inhibitor (Ki = 1.3 pM for wild-type enzyme); inhibits the replication of clinical isolates of HIV-1 (EC50s = 5-52 nM); reduces the infectious virus yield and viral RNA copy numbers in the culture supernatant of Vero E6 cells infected with SARS-CoV-2 (EC50s = 26.63 and 26.10 µM, respectively); reduces lung and kidney viral load, bronchointerstitial pneumonia, and pulmonary inflammatory cell infiltration in a marmoset model of MERS-CoV when administered in combination with ritonavir ,,
Formal name: N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-αS-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
Synonyms: A-157378.0|ABT-378
Molecular weight: 628.8
CAS: 192725-17-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Immunology & Inflammation|Pulmonary Diseases|COVID-19||Research Area|Immunology & Inflammation|Pulmonary Diseases|SARS||Research Area|Infectious Disease|Viral Diseases|Coronaviruses||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS